CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 68 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $17,573 | -13.1% | 10,217 | -23.7% | 0.00% | – |
Q1 2023 | $20,229 | -87.8% | 13,397 | -87.1% | 0.00% | – |
Q4 2022 | $166,279 | -14.3% | 103,924 | -22.3% | 0.00% | – |
Q3 2022 | $194,000 | -43.4% | 133,693 | -28.7% | 0.00% | – |
Q2 2022 | $343,000 | -83.1% | 187,542 | -75.3% | 0.00% | – |
Q1 2022 | $2,026,000 | -26.5% | 758,589 | +19.1% | 0.00% | -100.0% |
Q4 2021 | $2,758,000 | -51.1% | 636,946 | -42.6% | 0.00% | 0.0% |
Q3 2021 | $5,645,000 | -6.3% | 1,109,065 | +16.5% | 0.00% | 0.0% |
Q2 2021 | $6,026,000 | +272.9% | 952,017 | +355.3% | 0.00% | – |
Q1 2021 | $1,616,000 | +8.5% | 209,102 | -8.1% | 0.00% | – |
Q4 2020 | $1,490,000 | -19.9% | 227,449 | -18.7% | 0.00% | -100.0% |
Q3 2020 | $1,861,000 | -19.6% | 279,823 | +0.7% | 0.00% | 0.0% |
Q2 2020 | $2,315,000 | +118.6% | 277,845 | +101.3% | 0.00% | – |
Q1 2020 | $1,059,000 | -68.2% | 138,048 | -65.5% | 0.00% | -100.0% |
Q4 2019 | $3,328,000 | +16.0% | 400,455 | +3.0% | 0.00% | 0.0% |
Q3 2019 | $2,869,000 | -37.1% | 388,730 | -4.3% | 0.00% | 0.0% |
Q2 2019 | $4,559,000 | +114.8% | 406,357 | +105.9% | 0.00% | 0.0% |
Q1 2019 | $2,122,000 | -71.8% | 197,375 | -60.4% | 0.00% | -50.0% |
Q4 2018 | $7,521,000 | -10.9% | 498,092 | +9.2% | 0.00% | 0.0% |
Q3 2018 | $8,437,000 | -29.2% | 456,053 | -12.5% | 0.00% | -33.3% |
Q2 2018 | $11,913,000 | -0.0% | 521,108 | +24.4% | 0.00% | 0.0% |
Q1 2018 | $11,917,000 | +23.4% | 418,892 | -8.5% | 0.00% | +50.0% |
Q4 2017 | $9,660,000 | +63.5% | 457,619 | +40.7% | 0.00% | +100.0% |
Q3 2017 | $5,909,000 | +198.4% | 325,165 | +154.5% | 0.00% | 0.0% |
Q2 2017 | $1,980,000 | +942.1% | 127,776 | +1063.5% | 0.00% | – |
Q1 2017 | $190,000 | -40.4% | 10,982 | -28.1% | 0.00% | – |
Q4 2015 | $319,000 | – | 15,278 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
Manteio Capital LLC | 15,067 | $65,000 | 0.08% |